(Hypertension. 1995;26:78-82.)
© 1995 American Heart Association, Inc.
Articles |
Modulation of Left and Right Ventricular ß-Adrenergic Receptors From Spontaneously Hypertensive Rats With Left Ventricular Hypertrophy and Failure
From the Department of Veterans Affairs Medical Center; Department of Medicine, Boston University School of Medicine; Department of Medicine (Cardiovascular Division), Lemuel Shattuck Hospital; and Tufts University School of Medicine, Boston, Mass.
Abstract Inotropic responsiveness to ß-adrenergic stimulation is generally found to be depressed in cardiac hypertrophy and failure. To investigate whether inotropic responsiveness is associated with alterations in ß-adrenergic receptors in spontaneously hypertensive rats (SHR), we studied left ventricular myocardial contractile responses to isoproterenol and ß-adrenergic receptor density and affinity in age-matched rats (18 to 24 months), including SHR without heart failure, SHR with evidence of heart failure, and normotensive control Wistar-Kyoto rats (WKY). In the baseline state, papillary muscles from failing SHR demonstrated decreased isometric tension development and a reduction in maximal rate of tension development relative to normotensive WKY and compensated SHR. Compared with WKY, ß-adrenergic receptor density of the left ventricle was unchanged in nonfailing SHR and increased in failing SHR (P<.05 versus WKY and nonfailing SHR), and ß-adrenergic receptor affinity did not differ among groups. In the right ventricle, ß-adrenergic receptor density was decreased in failing SHR relative to WKY and nonfailing SHR, and ß-adrenergic receptor affinity was not different among groups. Muscle preparations did not exhibit a positive inotropic response to 10-8 to 10-5 mol/L isoproterenol or 6.3 µmol/L forskolin in either failing or nonfailing SHR, whereas a positive inotropic response to both drugs was observed in the normotensive WKY. The lusitropic response to isoproterenol and forskolin was intact and similar in both SHR groups and WKY. The findings suggest that in the SHR model of heart failure, impaired intrinsic left ventricular myocardial function and depressed inotropic responsiveness to ß-adrenergic stimulation are not associated with downregulation of the ß-adrenergic receptor. Impaired inotropic responses, with intact lusitropic responses, to both isoproterenol and forskolin are consistent with the concept that "downstream" events are responsible for impaired inotropy in response to ß-adrenergic stimulation in the SHR with chronic left ventricular hypertrophy and failure.
Key Words: receptors, adrenergic • ventricular hypertrophy, left • heart failure, congestive
This article has been cited by other articles:
 |
|
 |
|
  S. M. MacDonnell, J. Weisser-Thomas, H. Kubo, M. Hanscome, Q. Liu, N. Jaleel, R. Berretta, X. Chen, J. H. Brown, A.-K. Sabri, et al. CaMKII Negatively Regulates Calcineurin-NFAT Signaling in Cardiac Myocytes Circ. Res., August 14, 2009; 105(4): 316 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Kolwicz, H. Kubo, S. M. MacDonnell, S. R. Houser, and J. R. Libonati Effects of forskolin on inotropic performance and phospholamban phosphorylation in exercise-trained hypertensive myocardium J Appl Physiol, February 1, 2007; 102(2): 628 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. MacDonnell, H. Kubo, D. L. Crabbe, B. F. Renna, P. O. Reger, J. Mohara, L. A. Smithwick, W. J. Koch, S. R. Houser, and J. R. Libonati Improved Myocardial {beta}-Adrenergic Responsiveness and Signaling With Exercise Training in Hypertension Circulation, June 28, 2005; 111(25): 3420 - 3428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Kouchi, O. Zolk, F. Jockenhovel, G. Itter, W. Linz, B. Cremers, and M. Bohm Increase in Gi{alpha} Protein Accompanies Progression of Post-Infarction Remodeling in Hypertensive Cardiomyopathy Hypertension, July 1, 2000; 36(1): 42 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. W. Brooks, O. H. L. Bing, M. O. Boluyt, A. Malhotra, J. P. Morgan, N. Satoh, W. S. Colucci, and C. H. Conrad Altered Inotropic Responsiveness and Gene Expression of Hypertrophied Myocardium With Captopril Hypertension, June 1, 2000; 35(6): 1203 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Xu, S. J. Rials, Y. Wu, T. Liu, R. A. Marinchak, and P. R. Kowey Effects of Captopril Treatment of Renovascular Hypertension on beta -Adrenergic Modulation of L-Type Ca2+ Current J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 196 - 200. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Cerbai, R. Pino, M. L Rodriguez, and A. Mugelli Modulation of the pacemaker current If by {beta}-adrenoceptor subtypes in ventricular myocytes isolated from hypertensive and normotensive rats Cardiovasc Res, April 1, 1999; 42(1): 121 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Carroll, A. E. Jones, R. L. Hester, G. A. Reinhart, K. Cockrell, and H. L. Mizelle Reduced Cardiac Contractile Responsiveness to Isoproterenol in Obese Rabbits Hypertension, December 1, 1997; 30(6): 1376 - 1381. [Abstract] [Full Text]
|
|